1. Bortolozzi, Roberta, Bresolin, Silvia, Rampazzo, Elena, Basso, Giuseppe, Persano, Luca. 2018. AKR1C enzymes sustain therapy resistance in paediatric T-ALL. In British journal of cancer, 118, 985-994. doi:10.1038/s41416-018-0014-0. https://pubmed.ncbi.nlm.nih.gov/29515258/
2. Pratt-Hyatt, Matthew, Lickteig, Andrew J, Klaassen, Curtis D. 2013. Tissue distribution, ontogeny, and chemical induction of aldo-keto reductases in mice. In Drug metabolism and disposition: the biological fate of chemicals, 41, 1480-7. doi:10.1124/dmd.113.051904. https://pubmed.ncbi.nlm.nih.gov/23660342/
3. Bellamy, Jacob, Szemes, Marianna, Melegh, Zsombor, Catchpoole, Daniel, Malik, Karim. 2020. Increased Efficacy of Histone Methyltransferase G9a Inhibitors Against MYCN-Amplified Neuroblastoma. In Frontiers in oncology, 10, 818. doi:10.3389/fonc.2020.00818. https://pubmed.ncbi.nlm.nih.gov/32537432/
4. Tan, Chuan, Shard, Chloe, Ranieri, Enzo, Scheffer, Ingrid E, Gecz, Jozef. 2015. Mutations of protocadherin 19 in female epilepsy (PCDH19-FE) lead to allopregnanolone deficiency. In Human molecular genetics, 24, 5250-9. doi:10.1093/hmg/ddv245. https://pubmed.ncbi.nlm.nih.gov/26123493/